tricaprylin has been researched along with Alzheimer Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barr, LJ; Costantini, LC; Henderson, ST; Vogel, JL | 1 |
| Cummings, JL; Dilley, ML; Grill, JD; Lee, J; Ossinalde, C; Sethanandha, C; Silverman, DH; Torosyan, N | 1 |
1 review(s) available for tricaprylin and Alzheimer Disease
| Article | Year |
|---|---|
Hypometabolism as a therapeutic target in Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Apolipoproteins E; Brain; Cognition; Glucose; Humans; Ketone Bodies; Memory; Triglycerides | 2008 |
1 trial(s) available for tricaprylin and Alzheimer Disease
| Article | Year |
|---|---|
Changes in regional cerebral blood flow associated with a 45 day course of the ketogenic agent, caprylidene, in patients with mild to moderate Alzheimer's disease: Results of a randomized, double-blinded, pilot study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Apolipoproteins E; Brain; Brain Mapping; Cerebrovascular Circulation; Cognition; Diet, Ketogenic; Double-Blind Method; Female; Humans; Ketone Bodies; Male; Middle Aged; Pilot Projects; Positron-Emission Tomography; Triglycerides | 2018 |